Literature DB >> 14726655

Methylation status of RB1 promoter in Indian retinoblastoma patients.

Biju Joseph1, Gandra Mamatha, Gayathree Raman, Mahesh Palanivelu Shanmugam, Govindasamy Kumaramanickavel.   

Abstract

Retinoblastoma can arise due to mutational inactivation or methylation of RB1 gene promoter. A 600-bp CpG island consisting of the essential promoter is present at the 5' end of RB1 gene. Hypermethylation of the CpG island within the RB1 promoter region has been described in unilateral retinoblastoma. In vitro and in vivo studies have suggested that methylation of the RB1 promoter dramatically reduces gene activity. In the present study methylation status of the CpG island within the promoter region of RB1 gene has been evaluated by methylation specific polymerase chain reaction to define the molecular mechanism responsible for retinoblastoma in Indian patients. One unilateral and two bilateral nonhereditary patients had methylation of the RB1 promoter region in which 6.6% of our patients had complete methylation of the RB1 promoter region. This study shows methylation of RB1 promoter is not a major mechanism for retinoblastoma patients in India. Methylation analysis is used in genetic counseling of the family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726655     DOI: 10.4161/cbt.3.2.620

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  6 in total

Review 1.  Epigenetic regulation of human retinoblastoma.

Authors:  Usha Singh; Manzoor Ahmad Malik; Sandeep Goswami; Swati Shukla; Jasbir Kaur
Journal:  Tumour Biol       Date:  2016-09-17

2.  Retinoblastoma: genetic testing versus conventional clinical screening in India.

Authors:  Biju Joseph; Mahesh Palanivelu Shanmugam; Madhuravasal Krishnan Srinivasan; Govindasamy Kumaramanickavel
Journal:  Mol Diagn       Date:  2004

3.  Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala.

Authors:  Michael Dean; Giovana Bendfeldt; Hong Lou; Veronica Giron; Claudia Garrido; Patricia Valverde; Margarita Barnoya; Mauricio Castellanos; Silvia Jiménez-Morales; Sandra Luna-Fineman
Journal:  Cancer Lett       Date:  2014-05-06       Impact factor: 8.679

4.  Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer.

Authors:  Maimoona Sabir; Ruqia Mehmood Baig; Kashif Ali; Ishrat Mahjabeen; Muhammad Saeed; Mahmood Akhtar Kayani
Journal:  Cell Oncol (Dordr)       Date:  2014-06-03       Impact factor: 6.730

5.  Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.

Authors:  Mercedes Dávalos-Salas; Mayra Furlan-Magaril; Edgar González-Buendía; Christian Valdes-Quezada; Erandi Ayala-Ortega; Félix Recillas-Targa
Journal:  BMC Cancer       Date:  2011-06-10       Impact factor: 4.430

6.  CpG site methylation in CRYAA promoter affect transcription factor Sp1 binding in human lens epithelial cells.

Authors:  Xin Liu; Peng Zhou; Fan Fan; Dan Li; Jihong Wu; Yi Lu; Yi Luo
Journal:  BMC Ophthalmol       Date:  2016-08-09       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.